Cargando…
Decline in arylsulfatase B leads to increased invasiveness of melanoma cells
Arylsulfatase B (ARSB; N-acetylgalactosamine 4-sulfatase) is reduced in several malignancies, but levels in melanoma have not been investigated previously. Experiments were performed in melanoma cell lines to determine ARSB activity and impact on melanoma invasiveness. ARSB activity was reduced ~50%...
Autores principales: | Bhattacharyya, Sumit, Feferman, Leo, Terai, Kaoru, Dudek, Arkadiusz Z., Tobacman, Joanne K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354821/ https://www.ncbi.nlm.nih.gov/pubmed/27926479 http://dx.doi.org/10.18632/oncotarget.13751 |
Ejemplares similares
-
Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect
por: Bhattacharyya, Sumit, et al.
Publicado: (2016) -
Arylsulfatase B Regulates Versican Expression by Galectin-3 and AP-1 Mediated Transcriptional Effects
por: Bhattacharyya, Sumit, et al.
Publicado: (2013) -
Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity
por: Bhattacharyya, Sumit, et al.
Publicado: (2020) -
Hypoxia Reduces Arylsulfatase B Activity and Silencing Arylsulfatase B Replicates and Mediates the Effects of Hypoxia
por: Bhattacharyya, Sumit, et al.
Publicado: (2012) -
Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases
por: Tobacman, Joanne K., et al.
Publicado: (2022)